Notes And Other Explanatory Information [Abstract]

ABIONYX Pharma - Filing #2813091

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
III ESTIMATIONS ET JUGEMENTS COMPTABLES SIGNIFICATIFS
Disclosure of auditors' remuneration [text block]
HONORAIRES DES COMMISSAIRES AUX COMPTES
Disclosure of authorisation of financial statements [text block]
Les comptes consolidés IFRS de l’exercice clos au 31 décembre 2022 ont été arrêtés par le conseil d’administration du 13 avril 2023.
Disclosure of basis of consolidation [text block]
II METHODES DE CONSOLIDATION
Disclosure of borrowings [text block]
Soldes et explications
Disclosure of cash and cash equivalents [text block]
Soldes et explications
Disclosure of cash flow statement [text block]
XXX TABLEAU DE FLUX DE TRESORERIE
Disclosure of changes in accounting policies [text block]
iii. Application des normes et interprétations en vigueur au 31 décembre 2021
Disclosure of contingent liabilities [text block]
OBLIGATIONS CONTRACTUELLES – PASSIF EVENTUEL ET REMUNERATION CONDITIONNELLE
Disclosure of cost of sales [text block]
XXIV COUTS DES BIENS ET SERVICES VENDUS
Disclosure of credit risk [text block]
Disclosure of deferred taxes [text block]
iii. Impôts différés
Disclosure of earnings per share [text block]
Soldes et explications
Disclosure of effect of changes in foreign exchange rates [text block]
:
Disclosure of employee benefits [text block]
ii) Engagements de retraite
Disclosure of entity's operating segments [text block]
Soldes et explications
Disclosure of events after reporting period [text block]
B) Evènements postérieurs à la clôture
Disclosure of fair value of financial instruments [text block]
ii. Juste valeur
Disclosure of financial instruments [text block]
Soldes et explications
Disclosure of financial risk management [text block]
XXXI GESTION ET EVALUATION DES RISQUES FINANCIERS
Disclosure of general and administrative expense [text block]
XXVI FRAIS ADMINSITRATIFS ET COMMERCIAUX
Disclosure of general information about financial statements [text block]
PRESENTATION DU GROUPE
Disclosure of goodwill [text block]
Soldes et explications
Disclosure of government grants [text block]
Disclosure of income tax [text block]
XXVIII IMPOTS
Disclosure of information about employees [text block]
Disclosure of intangible assets [text block]
Soldes et explications
Disclosure of interest income (expense) [text block]
XXVII CHARGES ET PRODUITS FINANCIERS
Disclosure of inventories [text block]
Soldes et explications
Disclosure of issued capital [text block]
Soldes et explications
Disclosure of leases [text block]
Soldes et explications
Disclosure of liquidity risk [text block]
Disclosure of market risk [text block]
Disclosure of other current assets [text block]
XII AUTRES ACTIFS COURANTS
Disclosure of other current liabilities [text block]
Soldes et explications
Disclosure of property, plant and equipment [text block]
Soldes et explications
Disclosure of provisions [text block]
Soldes et explications
Disclosure of related party [text block]
PARTIES LIEES
Disclosure of revenue from contracts with customers [text block]
XXIII CHIFFRE D’AFFAIRES – RECONNAISSANCE DU REVENU
Disclosure of share capital, reserves and other equity interest [text block]
XIV CAPITAL ET FRAIS D’AUGMENTATION DE CAPITAL
Disclosure of share-based payment arrangements [text block]
Soldes et explications
Disclosure of subsidiaries [text block]
Disclosure of trade and other payables [text block]
Soldes et explications
Disclosure of trade and other receivables [text block]
Soldes et explications

Talk to a Data Expert

Have a question? We'll get back to you promptly.